{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:15:54Z","timestamp":1783098954206,"version":"3.54.6"},"reference-count":56,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372606"],"award-info":[{"award-number":["82372606"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82301093"],"award-info":[{"award-number":["82301093"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871899"],"award-info":[{"award-number":["81871899"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473120"],"award-info":[{"award-number":["82473120"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017686","name":"Fujian Provincial Health Technology Project","doi-asserted-by":"publisher","award":["2023GGA016"],"award-info":[{"award-number":["2023GGA016"]}],"id":[{"id":"10.13039\/501100017686","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017682","name":"Construction Project of Fujian Province Minimally Invasive Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017682","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Fujian Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2020J011001"],"award-info":[{"award-number":["2020J011001"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Fujian Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2022J06021"],"award-info":[{"award-number":["2022J06021"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Fujian Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2025J02020"],"award-info":[{"award-number":["2025J02020"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013795","name":"Fujian Medical University","doi-asserted-by":"publisher","award":["2022XH041"],"award-info":[{"award-number":["2022XH041"]}],"id":[{"id":"10.13039\/501100013795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013795","name":"Fujian Medical University","doi-asserted-by":"publisher","award":["2022XH021"],"award-info":[{"award-number":["2022XH021"]}],"id":[{"id":"10.13039\/501100013795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.xcrm.2026.102635","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T15:40:40Z","timestamp":1772034040000},"page":"102635","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Enhancing gastric cancer immunotherapy: Insights from multi-omics analysis and innovations in photodynamic-chemotherapy nanoplatforms"],"prefix":"10.1016","volume":"7","author":[{"given":"Qing-Zhu","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Xin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Xuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deng-Hui","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Peng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong-Xing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Yang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-Ning","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao-Ling","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Hong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Hui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Wei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiyo","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Yue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0019-885X","authenticated-orcid":false,"given":"Chang-Ming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.102635_bib1","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1016\/j.cell.2021.09.020","article-title":"Hallmarks of response, resistance, and toxicity to immune checkpoint blockade","volume":"184","author":"Morad","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102635_bib2","first-page":"264","article-title":"Current treatment and recent progress in gastric cancer","volume":"71","author":"Joshi","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.xcrm.2026.102635_bib3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41392-020-00449-4","article-title":"Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy","volume":"6","author":"Tang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.xcrm.2026.102635_bib4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to treat immune hot, altered and cold tumours with combination immunotherapies","volume":"18","author":"Galon","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2026.102635_bib5","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102635_bib6","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","article-title":"The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications","volume":"17","author":"Zhang","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.xcrm.2026.102635_bib7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/cac2.12078","article-title":"Single-cell RNA sequencing in breast cancer: Understanding tumor heterogeneity and paving roads to individualized therapy","volume":"40","author":"Ding","year":"2020","journal-title":"Cancer Commun."},{"key":"10.1016\/j.xcrm.2026.102635_bib8","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13045-023-01494-6","article-title":"Advances in single-cell RNA sequencing and its applications in cancer research","volume":"16","author":"Huang","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.xcrm.2026.102635_bib9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41586-021-03634-9","article-title":"Exploring tissue architecture using spatial transcriptomics","volume":"596","author":"Rao","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102635_bib10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.molcel.2019.05.003","article-title":"Single-Cell RNA Sequencing in Cancer: Lessons Learned and Emerging Challenges","volume":"75","author":"Suv\u00e0","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.xcrm.2026.102635_bib11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41467-022-35431-x","article-title":"Neoadjuvant therapy with immune checkpoint blockade, antiangiogenesis, and chemotherapy for locally advanced gastric cancer","volume":"14","author":"Li","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102635_bib12","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41571-023-00783-w","article-title":"Optimizing the safety of antibody-drug conjugates for patients with solid tumours","volume":"20","author":"Tarantino","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2026.102635_bib13","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41401-022-00953-z","article-title":"Immune-based combination therapy to convert immunologically cold tumors into hot tumors: an update and new insights","volume":"44","author":"Ni","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.xcrm.2026.102635_bib14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.semcancer.2020.02.003","article-title":"Turning liabilities into opportunities: Off-target based drug repurposing in cancer","volume":"68","author":"Palve","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.xcrm.2026.102635_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2017.06.003","article-title":"Nanoformulations for combination or cascade anticancer therapy","volume":"115","author":"Miao","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.xcrm.2026.102635_bib16","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1002\/adhm.201500129","article-title":"Macrophage Cell Membrane Camouflaged Mesoporous Silica Nanocapsules for In Vivo Cancer Therapy","volume":"4","author":"Xuan","year":"2015","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.xcrm.2026.102635_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202002054","article-title":"Engineering Macrophages for Cancer Immunotherapy and Drug Delivery","volume":"32","author":"Xia","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.xcrm.2026.102635_bib18","article-title":"Hollow Nanomaterials in Advanced Drug Delivery Systems: From Single- to Multiple Shells","volume":"35","author":"Li","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.xcrm.2026.102635_bib19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1126\/science.aad0501","article-title":"Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq","volume":"352","author":"Tirosh","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.102635_bib20","first-page":"9","article-title":"YAP\/TAZ as master regulators in cancer: modulation, function and therapeutic approaches","volume":"4","author":"Piccolo","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.xcrm.2026.102635_bib21","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001358","article-title":"Deep immunophenotyping at the single-cell level identifies a combination of anti-IL-17 and checkpoint blockade as an effective treatment in a preclinical model of data-guided personalized immunotherapy","volume":"8","author":"Nagaoka","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.xcrm.2026.102635_bib22","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s10120-024-01514-5","article-title":"Janus kinase inhibitor overcomes resistance to immune checkpoint inhibitor treatment in peritoneal dissemination of gastric cancer in C57BL\/6 J mice","volume":"27","author":"Du","year":"2024","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.xcrm.2026.102635_bib23","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41587-021-00830-w","article-title":"Robust decomposition of cell type mixtures in spatial transcriptomics","volume":"40","author":"Cable","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2026.102635_bib24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41575-019-0126-x","article-title":"Immunotherapy in colorectal cancer: rationale, challenges and potential","volume":"16","author":"Ganesh","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.xcrm.2026.102635_bib25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/CJI.0000000000000316","article-title":"Positive Status of Epstein-Barr Virus as a Biomarker for Gastric Cancer Immunotherapy: A Prospective Observational Study","volume":"43","author":"Xie","year":"2020","journal-title":"J. Immunother."},{"key":"10.1016\/j.xcrm.2026.102635_bib26","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1056\/NEJMoa2201445","article-title":"PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer","volume":"386","author":"Cercek","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102635_bib27","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nrd2110","article-title":"The mighty mouse: genetically engineered mouse models in cancer drug development","volume":"5","author":"Sharpless","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2026.102635_bib28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2015.08.068","article-title":"Preclinical mouse cancer models: a maze of opportunities and challenges","volume":"163","author":"Day","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102635_bib29","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nrgastro.2016.59","article-title":"The Hippo pathway in intestinal regeneration and disease","volume":"13","author":"Hong","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.xcrm.2026.102635_bib30","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.7150\/thno.40889","article-title":"A combat with the YAP\/TAZ-TEAD oncoproteins for cancer therapy","volume":"10","author":"Pobbati","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.xcrm.2026.102635_bib31","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nrm.2017.87","article-title":"Mechanobiology of YAP and TAZ in physiology and disease","volume":"18","author":"Panciera","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.xcrm.2026.102635_bib32","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1038\/bjc.2014.95","article-title":"Phase I\/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer","volume":"110","author":"Huggett","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.xcrm.2026.102635_bib33","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJMoa062655","article-title":"Ranibizumab versus verteporfin for neovascular age-related macular degeneration","volume":"355","author":"Brown","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102635_bib34","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1021\/acs.nanolett.7b05263","article-title":"Macrophage-Membrane-Coated Nanoparticles for Tumor-Targeted Chemotherapy","volume":"18","author":"Zhang","year":"2018","journal-title":"Nano Lett."},{"key":"10.1016\/j.xcrm.2026.102635_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202207593","article-title":"Synergistic Reinforcing of Immunogenic Cell Death and Transforming Tumor-Associated Macrophages Via a Multifunctional Cascade Bioreactor for Optimizing Cancer Immunotherapy. Advanced Materials n\/a","volume":"34","author":"Huang","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.xcrm.2026.102635_bib36","doi-asserted-by":"crossref","first-page":"7738","DOI":"10.1021\/acsnano.6b03148","article-title":"Liposomes Coated with Isolated Macrophage Membrane Can Target Lung Metastasis of Breast Cancer","volume":"10","author":"Cao","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.xcrm.2026.102635_bib37","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cell.2020.03.048","article-title":"Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon Cancer","volume":"181","author":"Zhang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102635_bib38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1172\/JCI121266","article-title":"Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target","volume":"129","author":"Wei","year":"2019","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.102635_bib39","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13045-017-0421-3","article-title":"Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways","volume":"10","author":"Huang","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.xcrm.2026.102635_bib40","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41568-024-00674-x","article-title":"Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity","volume":"24","author":"Meier","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2026.102635_bib41","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrc3258","article-title":"Cancer immunotherapy via dendritic cells","volume":"12","author":"Palucka","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2026.102635_bib42","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1038\/s41467-018-05388-x","article-title":"Contact inhibition controls cell survival and proliferation via YAP\/TAZ-autophagy axis","volume":"9","author":"Pavel","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102635_bib43","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/ng.3218","article-title":"The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies","volume":"47","author":"Lin","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xcrm.2026.102635_bib44","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.cell.2016.11.005","article-title":"The Hippo Pathway Kinases LATS1\/2 Suppress Cancer Immunity","volume":"167","author":"Moroishi","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102635_bib45","article-title":"Targeting YAP1 to improve the efficacy of immune checkpoint inhibitors in liver cancer: mechanism and strategy","volume":"15","author":"Gao","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.102635_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2017.205","article-title":"Hippo pathway coactivators Yap and Taz are required to coordinate mammalian liver regeneration","volume":"50","author":"Lu","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.xcrm.2026.102635_bib47","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1681\/ASN.2014090916","article-title":"Podocyte-Specific Deletion of Yes-Associated Protein Causes FSGS and Progressive Renal Failure","volume":"27","author":"Schwartzman","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.xcrm.2026.102635_bib48","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/hep.25769","article-title":"Yes-associated protein regulates the hepatic response after bile duct ligation","volume":"56","author":"Bai","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.xcrm.2026.102635_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.557429","article-title":"The Role of Photoactivated and Non-Photoactivated Verteporfin on Tumor","volume":"11","author":"Wei","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.xcrm.2026.102635_bib55","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","article-title":"Dictionary learning for integrative, multimodal and scalable single-cell analysis","volume":"42","author":"Hao","year":"2024","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.xcrm.2026.102635_bib56","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","article-title":"Inference and analysis of cell-cell communication using CellChat","volume":"12","author":"Jin","year":"2021","journal-title":"Nature Communications"},{"key":"10.1016\/j.xcrm.2026.102635_bib50","article-title":"Tumor Immunophenotyping-Derived Signature Identifies Prognosis and Neoadjuvant Immunotherapeutic Responsiveness in Gastric Cancer","volume":"10","author":"Wang","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.xcrm.2026.102635_bib51","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.xcrm.2026.102635_bib52","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/SLA.0b013e318216f449","article-title":"Significance of histopathological tumor regression after neoadjuvant chemotherapy in gastric adenocarcinomas: a summary of 480 cases","volume":"253","author":"Becker","year":"2011","journal-title":"Ann. Surg."},{"key":"10.1016\/j.xcrm.2026.102635_bib53","article-title":"Development of Facile and Versatile Platinum Drug Delivering Silicasome Nanocarriers for Efficient Pancreatic Cancer Chemo-Immunotherapy","volume":"17","author":"Liu","year":"2021","journal-title":"Small"},{"key":"10.1016\/j.xcrm.2026.102635_bib54","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126000522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126000522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T16:19:21Z","timestamp":1783095561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126000522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2666379126000522"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102635","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancing gastric cancer immunotherapy: Insights from multi-omics analysis and innovations in photodynamic-chemotherapy nanoplatforms","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102635","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102635"}}